Follow-Up Study for Exubera (FUSE)
24 settembre 2012 aggiornato da: Pfizer
An Observational Follow-Up Study Of Patients Previously Enrolled In Exubera Controlled Clinical Trials
In studies of Exubera in persons with diabetes, lung cancer occurred in a few more people who were taking Exubera than in people who were taking other diabetes medicines.
All subjects diagnosed with lung cancer had a history of smoking and the number of lung cancer cases observed fell within the expected range based on population-based data.
There is currently not enough information to determine if any of the observed lung cancer cases were related to Exubera use, therefore, the study is being conducted to further investigate whether Exubera use makes the appearance of lung cancer more likely.
Panoramica dello studio
Stato
Completato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
Both retrospective and prospective components All subjects who participated in one of the 17 included Exubera clinical trials will be invited to participate in the current study.
Tipo di studio
Osservativo
Iscrizione (Effettivo)
7439
Contatti e Sedi
Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.
Luoghi di studio
-
-
-
Buenos Aires, Argentina, C1426ABP
- Pfizer Investigational Site
-
-
Buenos Aires
-
Capital Federal, Buenos Aires, Argentina, C1181ACH
- Pfizer Investigational Site
-
-
-
-
New South Wales
-
Camperdown, New South Wales, Australia, 2050
- Pfizer Investigational Site
-
Wollongong, New South Wales, Australia, 2500
- Pfizer Investigational Site
-
-
Queensland
-
Herston, Queensland, Australia, 4029
- Pfizer Investigational Site
-
-
Victoria
-
Box Hill, Victoria, Australia, 3128
- Pfizer Investigational Site
-
Melbourne, Victoria, Australia, 3004
- Pfizer Investigational Site
-
-
-
-
-
Vienna, Austria, A-1130
- Pfizer Investigational Site
-
Wien, Austria, A-1030
- Pfizer Investigational Site
-
-
-
-
-
Bornem, Belgio, 2880
- Pfizer Investigational Site
-
Brussels, Belgio, 1070
- Pfizer Investigational Site
-
Edegem, Belgio, 2650
- Pfizer Investigational Site
-
Genk, Belgio, 3600
- Pfizer Investigational Site
-
Leuven, Belgio, 3000
- Pfizer Investigational Site
-
Liège 1, Belgio, 4000
- Pfizer Investigational Site
-
-
-
-
MG
-
Belo Horizonte, MG, Brasile, 30150-221
- Pfizer Investigational Site
-
-
RS
-
Porto Alegre, RS, Brasile, 90035-170
- Pfizer Investigational Site
-
-
SP
-
Sao Paulo, SP, Brasile, 01244-030
- Pfizer Investigational Site
-
Sao Paulo, SP, Brasile, 04025-011
- Pfizer Investigational Site
-
-
-
-
Alberta
-
Calgary, Alberta, Canada, T2L 1K8
- Pfizer Investigational Site
-
Calgary, Alberta, Canada, T2T 5C7
- Pfizer Investigational Site
-
Calgary, Alberta, Canada, T3B 0M3
- Pfizer Investigational Site
-
Edmonton, Alberta, Canada, T5J 3N4
- Pfizer Investigational Site
-
Edmonton, Alberta, Canada, T6G 2C8
- Pfizer Investigational Site
-
Edmonton, Alberta, Canada, T6G 2S2
- Pfizer Investigational Site
-
Red Deer, Alberta, Canada, T6N 6V7
- Pfizer Investigational Site
-
-
British Columbia
-
Victoria, British Columbia, Canada, V8R 1J8
- Pfizer Investigational Site
-
-
Manitoba
-
Winnipeg, Manitoba, Canada, R3E 3P4
- Pfizer Investigational Site
-
-
Newfoundland and Labrador
-
St. John's, Newfoundland and Labrador, Canada, A1A 2E2
- Pfizer Investigational Site
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canada, B3H 1V7
- Pfizer Investigational Site
-
Halifax, Nova Scotia, Canada, B3H 2Y9
- Pfizer Investigational Site
-
-
Ontario
-
Corunna, Ontario, Canada, N0N 1G0
- Pfizer Investigational Site
-
London, Ontario, Canada, N6A 4V2
- Pfizer Investigational Site
-
Mississauga, Ontario, Canada, L5M 2V8
- Pfizer Investigational Site
-
Oakville, Ontario, Canada, L6H 3P1
- Pfizer Investigational Site
-
Ottawa, Ontario, Canada, K1H 1A2
- Pfizer Investigational Site
-
Smiths Falls, Ontario, Canada, K7A 4W8
- Pfizer Investigational Site
-
Thornhill, Ontario, Canada, L4J 8L7
- Pfizer Investigational Site
-
Toronto, Ontario, Canada, M4N-3M5
- Pfizer Investigational Site
-
Toronto, Ontario, Canada, M4R 2G4
- Pfizer Investigational Site
-
-
Quebec
-
Chicoutimi, Quebec, Canada, G7H 5H6
- Pfizer Investigational Site
-
Gatineau, Quebec, Canada, J8Y 6S9
- Pfizer Investigational Site
-
Greenfield Park, Quebec, Canada, J4V 2H1
- Pfizer Investigational Site
-
Laval, Quebec, Canada, H7T 2P5
- Pfizer Investigational Site
-
Montreal, Quebec, Canada, H3A 1A1
- Pfizer Investigational Site
-
Sherbrooke, Quebec, Canada, J1H 5N4
- Pfizer Investigational Site
-
Trois Rivieres, Quebec, Canada, G8T 7A1
- Pfizer Investigational Site
-
-
-
-
-
Zagreb, Croazia, 10000
- Pfizer Investigational Site
-
Zagreb, Croazia, 10 000
- Pfizer Investigational Site
-
-
-
-
-
Aarhus, Danimarca, 8000
- Pfizer Investigational Site
-
Copenhagen, Danimarca, 2400
- Pfizer Investigational Site
-
Herning, Danimarca, 7400
- Pfizer Investigational Site
-
-
-
-
-
Pärnu, Estonia, 80018
- Pfizer Investigational Site
-
Tallinn, Estonia, 10318
- Pfizer Investigational Site
-
Tallinn, Estonia, 11625
- Pfizer Investigational Site
-
Tallinn, Estonia, 13415
- Pfizer Investigational Site
-
-
Viljandi mk.
-
Viljandi, Viljandi mk., Estonia, 71024
- Pfizer Investigational Site
-
-
-
-
-
Kuopio, Finlandia, 70210
- Pfizer Investigational Site
-
Lahti, Finlandia, 15110
- Pfizer Investigational Site
-
Lohja, Finlandia, 08200
- Pfizer Investigational Site
-
Oulu, Finlandia, 90100
- Pfizer Investigational Site
-
-
-
-
-
Amiens cedex 1, Francia, 80094
- Pfizer Investigational Site
-
Armentieres, Francia, 59427
- Pfizer Investigational Site
-
Besancon, Francia, 25030
- Pfizer Investigational Site
-
Bondy Cedex, Francia, 93143
- Pfizer Investigational Site
-
Brest CEDEX, Francia, 29609
- Pfizer Investigational Site
-
Chartres, Francia, 28000
- Pfizer Investigational Site
-
Corbeil-Essonnes, Francia, 91100
- Pfizer Investigational Site
-
Lorient Cedex, Francia, 56322
- Pfizer Investigational Site
-
Paris Cedex 10, Francia, 75475
- Pfizer Investigational Site
-
Paris Cedex 18, Francia, 75877
- Pfizer Investigational Site
-
Rennes Cedex 2, Francia, 35203
- Pfizer Investigational Site
-
-
-
-
-
Altenburg, Germania, 04600
- Pfizer Investigational Site
-
Aschaffenburg, Germania, 63739
- Pfizer Investigational Site
-
Bad Doberan, Germania, 18209
- Pfizer Investigational Site
-
Berlin, Germania, 10115
- Pfizer Investigational Site
-
Berlin, Germania, 13355
- Pfizer Investigational Site
-
Bonn, Germania, 53179
- Pfizer Investigational Site
-
Chemnitz, Germania, 09130
- Pfizer Investigational Site
-
Datteln, Germania, 45711
- Pfizer Investigational Site
-
Dortmund, Germania, 44339
- Pfizer Investigational Site
-
Eisenach, Germania, 99817
- Pfizer Investigational Site
-
Emden, Germania, 26725
- Pfizer Investigational Site
-
Essen, Germania, 45329
- Pfizer Investigational Site
-
Falkensee, Germania, 14612
- Pfizer Investigational Site
-
Friedberg, Germania, 86316
- Pfizer Investigational Site
-
Fulda, Germania, 36037
- Pfizer Investigational Site
-
Hamburg, Germania, 21073
- Pfizer Investigational Site
-
Hohenmoelsen, Germania, 06679
- Pfizer Investigational Site
-
Leipzig, Germania, 04103
- Pfizer Investigational Site
-
Leverkusen, Germania, 51371
- Pfizer Investigational Site
-
Marl, Germania, 45770
- Pfizer Investigational Site
-
Meissen, Germania, 01662
- Pfizer Investigational Site
-
Mittweida, Germania, 09648
- Pfizer Investigational Site
-
Muenchen, Germania, D-80469
- Pfizer Investigational Site
-
Muenster, Germania, 48145
- Pfizer Investigational Site
-
Muenster, Germania, 48153
- Pfizer Investigational Site
-
Neuss, Germania, 41460
- Pfizer Investigational Site
-
Reinfeld, Germania, 23858
- Pfizer Investigational Site
-
Riesa, Germania, 01587
- Pfizer Investigational Site
-
Rossach, Germania, 96269
- Pfizer Investigational Site
-
Schluechtern, Germania, 36381
- Pfizer Investigational Site
-
Siegen, Germania, 57072
- Pfizer Investigational Site
-
Suhl, Germania, 98529
- Pfizer Investigational Site
-
Surwold, Germania, 26903
- Pfizer Investigational Site
-
Villingen-Schwenningen, Germania, 78054
- Pfizer Investigational Site
-
Wangen, Germania, 88239
- Pfizer Investigational Site
-
Wangen / Allgaeu, Germania, 88239
- Pfizer Investigational Site
-
Warburg, Germania, 34414
- Pfizer Investigational Site
-
Wiesbaden, Germania, 65191
- Pfizer Investigational Site
-
-
-
-
-
Athens, Grecia, 11527
- Pfizer Investigational Site
-
Athens, Grecia, 15123
- Pfizer Investigational Site
-
Thessaloniki, Grecia, 546 36
- Pfizer Investigational Site
-
-
-
-
-
Catania, Italia, 95122
- Pfizer Investigational Site
-
Genova, Italia, 16132
- Pfizer Investigational Site
-
Milano, Italia, 20132
- Pfizer Investigational Site
-
Napoli, Italia, 80131
- Pfizer Investigational Site
-
Padova, Italia, 35128
- Pfizer Investigational Site
-
Palermo, Italia, 90127
- Pfizer Investigational Site
-
Roma, Italia, 00133
- Pfizer Investigational Site
-
Udine, Italia, 33100
- Pfizer Investigational Site
-
-
-
-
Jalisco
-
Guadalajara, Jalisco, Messico, 44340
- Pfizer Investigational Site
-
-
Nuevo Leon
-
Monterrey, Nuevo Leon, Messico, 64460
- Pfizer Investigational Site
-
-
-
-
-
Fornebu, Norvegia, 1364
- Pfizer Investigational Site
-
Honefoss, Norvegia, 3515
- Pfizer Investigational Site
-
Skedsmokorset, Norvegia, N-2020
- Pfizer Investigational Site
-
Stavanger, Norvegia, 4068
- Pfizer Investigational Site
-
-
-
-
-
's Hertogenbosch, Olanda, 5211 RW
- Pfizer Investigational Site
-
Amsterdam, Olanda, 1105 AZ
- Pfizer Investigational Site
-
Beek, Olanda, 6191 JW
- Pfizer Investigational Site
-
Eindhoven, Olanda, 5631 BM
- Pfizer Investigational Site
-
Venlo, Olanda, 5912 BL
- Pfizer Investigational Site
-
-
-
-
-
Lask, Polonia, 98-100
- Pfizer Investigational Site
-
Lodz, Polonia, 93-338
- Pfizer Investigational Site
-
Lublin, Polonia, 20-536
- Pfizer Investigational Site
-
Warszawa, Polonia, 02-097
- Pfizer Investigational Site
-
-
-
-
-
Aveiro, Portogallo, 3814-096
- Pfizer Investigational Site
-
Lisboa, Portogallo, 1250-203
- Pfizer Investigational Site
-
Lisboa, Portogallo, 1349-019
- Pfizer Investigational Site
-
Porto, Portogallo, 4099-001
- Pfizer Investigational Site
-
Torres Vedras, Portogallo, 2560-324
- Pfizer Investigational Site
-
-
-
-
-
Bath, Regno Unito, BA2 3HT
- Pfizer Investigational Site
-
Bath, Regno Unito, BA2 4BY
- Pfizer Investigational Site
-
Birmingham, Regno Unito, B37 7TR
- Pfizer Investigational Site
-
Birmingham, Regno Unito, B9 5SS
- Pfizer Investigational Site
-
Bolton, Regno Unito, BL3 6TL
- Pfizer Investigational Site
-
Canterbury, Regno Unito, CT1 3HX
- Pfizer Investigational Site
-
Leicester, Regno Unito, LE1 5WW
- Pfizer Investigational Site
-
Newcastle-upon-Tyne, Regno Unito, NE15 6TQ
- Pfizer Investigational Site
-
Salford, Regno Unito, M6 8HD
- Pfizer Investigational Site
-
Westbury, Regno Unito, BA13 3JD
- Pfizer Investigational Site
-
-
Cornwall
-
Penzance, Cornwall, Regno Unito, TR18 4JH
- Pfizer Investigational Site
-
St. Austell, Cornwall, Regno Unito, PL26 7RL
- Pfizer Investigational Site
-
-
Devon
-
Plymouth, Devon, Regno Unito, PL6 8BX
- Pfizer Investigational Site
-
-
Hertfordshire
-
Letchworth, Hertfordshire, Regno Unito, SG6 4UB
- Pfizer Investigational Site
-
-
Middlesex
-
Ashford, Middlesex, Regno Unito, TW15 3EA
- Pfizer Investigational Site
-
-
Oxford
-
Headington, Oxford, Regno Unito, OX3 7LJ
- Pfizer Investigational Site
-
-
Surrey
-
Weybridge, Surrey, Regno Unito, KT15 2BH
- Pfizer Investigational Site
-
Woking, Surrey, Regno Unito, GU22 7EY
- Pfizer Investigational Site
-
-
Warwickshire
-
Rugby, Warwickshire, Regno Unito, CV22 5PX
- Pfizer Investigational Site
-
-
Wiltshire
-
Warminster, Wiltshire, Regno Unito, BA12 9AA
- Pfizer Investigational Site
-
-
Yorkshire
-
Sheffield, Yorkshire, Regno Unito, S7 2DW
- Pfizer Investigational Site
-
-
-
-
-
Banska Bystrica, Slovacchia, 975 17
- Pfizer Investigational Site
-
Bratislava, Slovacchia, 811 08
- Pfizer Investigational Site
-
Martin, Slovacchia, 036 01
- Pfizer Investigational Site
-
-
-
-
-
Barcelona, Spagna, 08036
- Pfizer Investigational Site
-
Granada, Spagna, 18012
- Pfizer Investigational Site
-
Madrid, Spagna, 28935
- Pfizer Investigational Site
-
Malaga, Spagna, 07300
- Pfizer Investigational Site
-
Sevilla, Spagna, 41014
- Pfizer Investigational Site
-
Valencia, Spagna, 46015
- Pfizer Investigational Site
-
-
A Coruña
-
Santiago de Compostela, A Coruña, Spagna, 15706
- Pfizer Investigational Site
-
-
Barcelona
-
Badalona, Barcelona, Spagna, 08916
- Pfizer Investigational Site
-
-
Las Palmas de Gran Canaria
-
Las Palmas, Las Palmas de Gran Canaria, Spagna, 35016
- Pfizer Investigational Site
-
-
Santa Cruz de Tenerife
-
La Laguna, Santa Cruz de Tenerife, Spagna, 38320
- Pfizer Investigational Site
-
-
Valencia
-
Alzira, Valencia, Spagna, 46600
- Pfizer Investigational Site
-
-
Vizcaya
-
Bilbao, Vizcaya, Spagna, 48013
- Pfizer Investigational Site
-
-
-
-
Alabama
-
Bay Minette, Alabama, Stati Uniti, 36507
- Pfizer Investigational Site
-
Graysville, Alabama, Stati Uniti, 35073
- Pfizer Investigational Site
-
Pell City, Alabama, Stati Uniti, 35125
- Pfizer Investigational Site
-
Pell City, Alabama, Stati Uniti, 35128
- Pfizer Investigational Site
-
-
Arizona
-
Glendale, Arizona, Stati Uniti, 85306
- Pfizer Investigational Site
-
Phoenix, Arizona, Stati Uniti, 85006
- Pfizer Investigational Site
-
Phoenix, Arizona, Stati Uniti, 85016
- Pfizer Investigational Site
-
Phoenix, Arizona, Stati Uniti, 85028
- Pfizer Investigational Site
-
Phoenix, Arizona, Stati Uniti, 85051
- Pfizer Investigational Site
-
-
Arkansas
-
Forrest City, Arkansas, Stati Uniti, 72335
- Pfizer Investigational Site
-
-
California
-
Berkeley, California, Stati Uniti, 94705
- Pfizer Investigational Site
-
Concord, California, Stati Uniti, 94520
- Pfizer Investigational Site
-
El Cajon, California, Stati Uniti, 92019
- Pfizer Investigational Site
-
Encino, California, Stati Uniti, 91436
- Pfizer Investigational Site
-
Fresno, California, Stati Uniti, 93720
- Pfizer Investigational Site
-
Fullerton, California, Stati Uniti, 92835
- Pfizer Investigational Site
-
Huntington Beach, California, Stati Uniti, 92648
- Pfizer Investigational Site
-
Long Beach, California, Stati Uniti, 90806
- Pfizer Investigational Site
-
Los Angeles, California, Stati Uniti, 90073
- Pfizer Investigational Site
-
Rolling Hills Estates, California, Stati Uniti, 90274
- Pfizer Investigational Site
-
San Diego, California, Stati Uniti, 92120
- Pfizer Investigational Site
-
San Diego, California, Stati Uniti, 92128
- Pfizer Investigational Site
-
San Jose, California, Stati Uniti, 95116
- Pfizer Investigational Site
-
Santa Ana, California, Stati Uniti, 92704
- Pfizer Investigational Site
-
Santa Barbara, California, Stati Uniti, 93105
- Pfizer Investigational Site
-
Tustin, California, Stati Uniti, 92780
- Pfizer Investigational Site
-
-
Colorado
-
Denver, Colorado, Stati Uniti, 80220
- Pfizer Investigational Site
-
Denver, Colorado, Stati Uniti, 80209
- Pfizer Investigational Site
-
Denver, Colorado, Stati Uniti, 80206
- Pfizer Investigational Site
-
Golden, Colorado, Stati Uniti, 80401
- Pfizer Investigational Site
-
Longmont, Colorado, Stati Uniti, 80501
- Pfizer Investigational Site
-
-
Connecticut
-
Milford, Connecticut, Stati Uniti, 06460
- Pfizer Investigational Site
-
-
Delaware
-
Newark, Delaware, Stati Uniti, 19713
- Pfizer Investigational Site
-
-
District of Columbia
-
Washington, District of Columbia, Stati Uniti, 20010
- Pfizer Investigational Site
-
Washington, District of Columbia, Stati Uniti, 20307
- Pfizer Investigational Site
-
-
Florida
-
Boca Raton, Florida, Stati Uniti, 33433
- Pfizer Investigational Site
-
Chiefland, Florida, Stati Uniti, 32626
- Pfizer Investigational Site
-
Green Cove Springs, Florida, Stati Uniti, 32043
- Pfizer Investigational Site
-
Kissimmee, Florida, Stati Uniti, 34743
- Pfizer Investigational Site
-
Lake City, Florida, Stati Uniti, 32025
- Pfizer Investigational Site
-
Lake Mary, Florida, Stati Uniti, 32746
- Pfizer Investigational Site
-
Miami, Florida, Stati Uniti, 33136
- Pfizer Investigational Site
-
Opa Locka, Florida, Stati Uniti, 33054-3818
- Pfizer Investigational Site
-
St. Cloud, Florida, Stati Uniti, 34769
- Pfizer Investigational Site
-
Tampa, Florida, Stati Uniti, 33624
- Pfizer Investigational Site
-
West Palm Beach, Florida, Stati Uniti, 33401
- Pfizer Investigational Site
-
-
Georgia
-
Atlanta, Georgia, Stati Uniti, 30342
- Pfizer Investigational Site
-
Atlanta, Georgia, Stati Uniti, 30318-2513
- Pfizer Investigational Site
-
Conyers, Georgia, Stati Uniti, 30013
- Pfizer Investigational Site
-
Decatur, Georgia, Stati Uniti, 30035
- Pfizer Investigational Site
-
-
Hawaii
-
Honolulu, Hawaii, Stati Uniti, 96813
- Pfizer Investigational Site
-
Honolulu, Hawaii, Stati Uniti, 96814
- Pfizer Investigational Site
-
-
Idaho
-
Hayden Lake, Idaho, Stati Uniti, 83835
- Pfizer Investigational Site
-
-
Illinois
-
Greenville, Illinois, Stati Uniti, 62246
- Pfizer Investigational Site
-
Normal, Illinois, Stati Uniti, 61761
- Pfizer Investigational Site
-
Olympia Fields, Illinois, Stati Uniti, 60461
- Pfizer Investigational Site
-
Springfield, Illinois, Stati Uniti, 62704
- Pfizer Investigational Site
-
-
Indiana
-
Fishers, Indiana, Stati Uniti, 46038
- Pfizer Investigational Site
-
Indianapolis, Indiana, Stati Uniti, 46229
- Pfizer Investigational Site
-
Indianapolis, Indiana, Stati Uniti, 46254-5472
- Pfizer Investigational Site
-
-
Iowa
-
Des Moines, Iowa, Stati Uniti, 50314
- Pfizer Investigational Site
-
Des Moines, Iowa, Stati Uniti, 50315
- Pfizer Investigational Site
-
Dubuque, Iowa, Stati Uniti, 52002
- Pfizer Investigational Site
-
-
Kansas
-
Wichita, Kansas, Stati Uniti, 67203
- Pfizer Investigational Site
-
-
Kentucky
-
Louisville, Kentucky, Stati Uniti, 40213
- Pfizer Investigational Site
-
Louisville, Kentucky, Stati Uniti, 40258
- Pfizer Investigational Site
-
Mount Sterling, Kentucky, Stati Uniti, 40353
- Pfizer Investigational Site
-
-
Maryland
-
Baltimore, Maryland, Stati Uniti, 21204
- Pfizer Investigational Site
-
Elkton, Maryland, Stati Uniti, 21921
- Pfizer Investigational Site
-
Glen Burnie, Maryland, Stati Uniti, 21061
- Pfizer Investigational Site
-
Wheaton, Maryland, Stati Uniti, 20902
- Pfizer Investigational Site
-
-
Massachusetts
-
Boston, Massachusetts, Stati Uniti, 02114
- Pfizer Investigational Site
-
Springfield, Massachusetts, Stati Uniti, 01105
- Pfizer Investigational Site
-
-
Michigan
-
Ann Arbor, Michigan, Stati Uniti, 48104
- Pfizer Investigational Site
-
Clinton, Michigan, Stati Uniti, 49236
- Pfizer Investigational Site
-
Flint, Michigan, Stati Uniti, 48532
- Pfizer Investigational Site
-
Muskegon, Michigan, Stati Uniti, 49444
- Pfizer Investigational Site
-
-
Minnesota
-
Saint Cloud, Minnesota, Stati Uniti, 56301
- Pfizer Investigational Site
-
-
Missouri
-
Kansas City, Missouri, Stati Uniti, 64116
- Pfizer Investigational Site
-
Springfield, Missouri, Stati Uniti, 65807
- Pfizer Investigational Site
-
-
Nevada
-
Incline Village, Nevada, Stati Uniti, 89452
- Pfizer Investigational Site
-
Las Vegas, Nevada, Stati Uniti, 89128
- Pfizer Investigational Site
-
-
New Jersey
-
Belvidere, New Jersey, Stati Uniti, 07823
- Pfizer Investigational Site
-
New Brunswick, New Jersey, Stati Uniti, 08901
- Pfizer Investigational Site
-
-
New Mexico
-
Albuquerque, New Mexico, Stati Uniti, 87106
- Pfizer Investigational Site
-
-
New York
-
Albany, New York, Stati Uniti, 12208
- Pfizer Investigational Site
-
Babylon, New York, Stati Uniti, 11702
- Pfizer Investigational Site
-
Brooklyn, New York, Stati Uniti, 11224
- Pfizer Investigational Site
-
Minneola, New York, Stati Uniti, 11501
- Pfizer Investigational Site
-
New Hartford, New York, Stati Uniti, 13413
- Pfizer Investigational Site
-
Syracuse, New York, Stati Uniti, 13210
- Pfizer Investigational Site
-
Williamsville, New York, Stati Uniti, 14221
- Pfizer Investigational Site
-
-
North Carolina
-
Asheboro, North Carolina, Stati Uniti, 27203
- Pfizer Investigational Site
-
Charlotte, North Carolina, Stati Uniti, 28227
- Pfizer Investigational Site
-
Durham, North Carolina, Stati Uniti, 27713
- Pfizer Investigational Site
-
Morehead City, North Carolina, Stati Uniti, 28557-3126
- Pfizer Investigational Site
-
Raleigh, North Carolina, Stati Uniti, 27609
- Pfizer Investigational Site
-
Tabor City, North Carolina, Stati Uniti, 28463
- Pfizer Investigational Site
-
Winston-Salem, North Carolina, Stati Uniti, 27103
- Pfizer Investigational Site
-
-
Ohio
-
Columbus, Ohio, Stati Uniti, 43207
- Pfizer Investigational Site
-
Dayton, Ohio, Stati Uniti, 45419
- Pfizer Investigational Site
-
Kettering, Ohio, Stati Uniti, 45429
- Pfizer Investigational Site
-
Marietta, Ohio, Stati Uniti, 45750
- Pfizer Investigational Site
-
-
Oregon
-
Portland, Oregon, Stati Uniti, 97210
- Pfizer Investigational Site
-
Portland, Oregon, Stati Uniti, 97232
- Pfizer Investigational Site
-
-
Pennsylvania
-
Fogelsville, Pennsylvania, Stati Uniti, 18051
- Pfizer Investigational Site
-
Hanover, Pennsylvania, Stati Uniti, 17331
- Pfizer Investigational Site
-
Harrisburg, Pennsylvania, Stati Uniti, 17112
- Pfizer Investigational Site
-
Jeannette, Pennsylvania, Stati Uniti, 15644
- Pfizer Investigational Site
-
Jersey Shore, Pennsylvania, Stati Uniti, 17740
- Pfizer Investigational Site
-
Lansdale, Pennsylvania, Stati Uniti, 19446
- Pfizer Investigational Site
-
Melrose Park, Pennsylvania, Stati Uniti, 19027
- Pfizer Investigational Site
-
Philadelphia, Pennsylvania, Stati Uniti, 19153-2326
- Pfizer Investigational Site
-
-
South Carolina
-
Charleston, South Carolina, Stati Uniti, 29412
- Pfizer Investigational Site
-
North Myrtle Beach, South Carolina, Stati Uniti, 29582
- Pfizer Investigational Site
-
-
Texas
-
Beaumont, Texas, Stati Uniti, 77701
- Pfizer Investigational Site
-
Dallas, Texas, Stati Uniti, 75246
- Pfizer Investigational Site
-
Houston, Texas, Stati Uniti, 77008
- Pfizer Investigational Site
-
Houston, Texas, Stati Uniti, 77079
- Pfizer Investigational Site
-
Kaufman, Texas, Stati Uniti, 75142
- Pfizer Investigational Site
-
San Antonio, Texas, Stati Uniti, 78229
- Pfizer Investigational Site
-
San Marcos, Texas, Stati Uniti, 78666
- Pfizer Investigational Site
-
Stephenville, Texas, Stati Uniti, 76401
- Pfizer Investigational Site
-
Webster, Texas, Stati Uniti, 77598
- Pfizer Investigational Site
-
-
Vermont
-
South Burlington, Vermont, Stati Uniti, 05403
- Pfizer Investigational Site
-
-
Virginia
-
Richmond, Virginia, Stati Uniti, 23225-4017
- Pfizer Investigational Site
-
Richmond, Virginia, Stati Uniti, 23294
- Pfizer Investigational Site
-
-
Washington
-
Federal Way, Washington, Stati Uniti, 98003
- Pfizer Investigational Site
-
Spokane, Washington, Stati Uniti, 99204
- Pfizer Investigational Site
-
Spokane, Washington, Stati Uniti, 99207
- Pfizer Investigational Site
-
-
West Virginia
-
Burnsville, West Virginia, Stati Uniti, 26335
- Pfizer Investigational Site
-
-
-
-
Gauteng
-
Houghton, Gauteng, Sud Africa, 2198
- Pfizer Investigational Site
-
-
KwaZulu Natal
-
Umhlanga Rocks, KwaZulu Natal, Sud Africa, 4320
- Pfizer Investigational Site
-
-
-
-
-
Boras, Svezia, 503 30
- Pfizer Investigational Site
-
Forshaga, Svezia, 667 32
- Pfizer Investigational Site
-
Goteborg, Svezia, 412 55
- Pfizer Investigational Site
-
Goteborg, Svezia, 41665
- Pfizer Investigational Site
-
Göteborg, Svezia, 417 17
- Pfizer Investigational Site
-
Harnosand, Svezia, 871 82
- Pfizer Investigational Site
-
Helsingborg, Svezia, 251 87
- Pfizer Investigational Site
-
Linkoping, Svezia, 581 85
- Pfizer Investigational Site
-
Malmo, Svezia, 211 52
- Pfizer Investigational Site
-
Stockholm, Svezia, 171 76
- Pfizer Investigational Site
-
Vaxjo, Svezia, 351 85
- Pfizer Investigational Site
-
-
Criteri di partecipazione
I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.
Criteri di ammissibilità
Età idonea allo studio
18 anni e precedenti (Adulto, Adulto più anziano)
Accetta volontari sani
No
Sessi ammissibili allo studio
Tutto
Metodo di campionamento
Campione non probabilistico
Popolazione di studio
All subjects who participated in a controlled trial of Exubera active within the last five years (17 protocols total)
Descrizione
Inclusion Criteria:
- Previously participated in an eligible Exubera clinical trial
- Willing to provide study doctor with at least one alternate contact person
Exclusion Criteria:
- Participated in an investigational study of an unapproved drug since completing the Exubera trial
- Ever used an other (non-Exubera) inhaled insulin
Piano di studio
Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.
Come è strutturato lo studio?
Dettagli di progettazione
- Modelli osservazionali: Coorte
Coorti e interventi
Gruppo / Coorte |
Intervento / Trattamento |
|---|---|
|
Previously treated with Exubera
|
Subjects who had been treated with Exubera in a prior Exubera controlled trial.
Following initial use of randomized treatment, physicians and subjects were free to change regimens and dosing based on subject response to assigned treatment (as consistent with routine practice).
|
|
Previously treated with comparator
Subjects who had been treated with a comparator (other diabetes treatment such as injected insulin) in a prior Exubera controlled trial.
|
Subjects who had been treated with a comparator (other diabetes treatment including one or more of: subcutaneous insulin, sulfonylureas, biguanides, or thiazolinediones) in a prior Exubera controlled trial. Following initial use of randomized treatment, physicians and subjects were free to change regimens and dosing based on subject response to assigned treatment (as consistent with routine practice). |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Rate of Primary Lung Cancer Mortality
Lasso di tempo: Baseline from original trial up to Year 2 of this study
|
Reported deaths from primary lung cancer were adjudicated and classified into 4 categories: highly likely (clinical, radiographic, and/or histological data consistent with primary lung cancer); likely (some information may have been missing for definite diagnosis); unlikely; insufficient information.
Highly likely and likely cases used to report rate and rate ratio of primary lung cancer mortality.
Includes events from the start of the original trial to the end of FUSE.
|
Baseline from original trial up to Year 2 of this study
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Rate of Primary Lung Cancer Mortality Among Former Smokers
Lasso di tempo: Baseline from original trial up to Year 2 of this study
|
Reported deaths from primary lung cancer were adjudicated and classified into 4 categories: highly likely (clinical, radiographic, and/or histological data consistent with primary lung cancer); likely (some information may have been missing for definite diagnosis); unlikely; insufficient information.
Highly likely and likely cases used to report rate and rate ratio of primary lung cancer mortality.
Includes events from the start of the original trial to the end of FUSE.
|
Baseline from original trial up to Year 2 of this study
|
|
Rate of All-cause Mortality
Lasso di tempo: Baseline from original trial up to Year 2 of this study
|
The rate and rate ratio of all-cause mortality that occurred anytime from the start of the original trial to the end of FUSE.
|
Baseline from original trial up to Year 2 of this study
|
|
Rate of Primary Lung Cancer Diagnosis
Lasso di tempo: Baseline from original trial up to Year 2 of this study
|
The rate and rate ratio of lung cancer adjudicated as highly likely (clinical, radiographic, and/or histological data consistent with primary lung cancer) or likely (some information may have been missing for definite diagnosis) to be newly diagnosed primary lung cancer that occurred anytime from the start of the original trial to the end of FUSE.
|
Baseline from original trial up to Year 2 of this study
|
Collaboratori e investigatori
Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.
Sponsor
Pubblicazioni e link utili
La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.
Studiare le date dei record
Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.
Studia le date principali
Inizio studio
1 agosto 2008
Completamento primario (Effettivo)
1 gennaio 2012
Completamento dello studio (Effettivo)
1 gennaio 2012
Date di iscrizione allo studio
Primo inviato
12 agosto 2008
Primo inviato che soddisfa i criteri di controllo qualità
12 agosto 2008
Primo Inserito (Stima)
14 agosto 2008
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
23 ottobre 2012
Ultimo aggiornamento inviato che soddisfa i criteri QC
24 settembre 2012
Ultimo verificato
1 settembre 2012
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Altri numeri di identificazione dello studio
- A2171121
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .